Categories AlphaGraphs, Earnings, Health Care
BMY Earnings: Highlights of Bristol-Myers Squibb’s Q3 2023 results
Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also provided guidance for fiscal 2023.
Net income attributable to shareholders was $1.93 billion or $0.93 per share in the September quarter, compared to $1.61 billion or $0.75 per share in the comparable period of 2022. Adjusted profit edged up to $2.0 per share in Q3 from $1.99 per share in the prior year period.
Third-quarter revenues decreased 2% from last year to $10.97 billion. Domestic revenues declined by 4%, while international revenues moved up 2%.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
DRI Earnings: Darden Restaurants’ Q2 2026 sales and profit rise YoY
Darden Restaurants, Inc. (NYSE: DRI), a leading fine dining restaurant chain, on Thursday reported an increase in sales and adjusted earnings for the second quarter of fiscal 2026. Total sales
CarMax (KMX) Q3 2026 earnings drop on lower sales; results beat estimates
Used car retailer CarMax, Inc. (NYSE: KMX) on Thursday reported a decline in earnings for the third quarter of fiscal 2026, hurt by lower sales. However, both revenues and earnings
ACN Earnings: Key quarterly highlights from Accenture’s Q1 2026 financial results
Accenture (NYSE: ACN) reported its first quarter 2026 earnings results today. Revenues of $18.7 billion increased 6% in US dollars and 5% in local currency compared to the same period a
